• Mashup Score: 0

    About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect® is a registered trademark of Elsevier B.V.ScienceDirect® is a registered trademark…

    Tweet Tweets with this article
    • 🔥🚨Hot off the press @TheLancet #IPSOS phase 3 trial of 1st line #Atezolizumab monotherapy vs single-agent #chemotherapy in pts with advanced #NSCLC ineligible for a platinum-containing chemo. Study showed better #OS & #Quality of life with Atezo. 👇🏼 https://t.co/0CCrBtCRZM https://t.co/07cNRS3SVP

  • Mashup Score: 0

    Vinay Prasad, MD MPH; Physician & Professor Hematologist/ OncologistProfessor of Epidemiology, Biostatistics and MedicineAuthor of 450+ Peer Reviewed papers,…

    Tweet Tweets with this article
    • Strongly recommend this awesome review by @VPrasadMDMPH to all #HemeOnc #Fellows! Very educational on so many aspects of clinical trial design and interpretation! #PFS #OS #Censoring #Crossover #bonus ➡️ good sense of humor ...read book #Malignant‼️ https://t.co/zGhdo1JVJU

  • Mashup Score: 3

    This document contains all the changes performed in DNS Manager 5.5.0.Important NotesBefore UpgradeUpgrade requires first the upgrade of the operating system to one of the supported versions:Red Hat Enterprise Linux 8AlmaLinux 8Rocky Linux 8The upgrade from CentOS 7 to AlmaLinux 8.6 is possible directly using the toolset released by AlmaLinux.InstallationIn order to install or upgrade to DNS…

    Tweet Tweets with this article
    • The new 5.5.0 version of #DNSManager provides support for #AlmaLinux OS 8, #RockyLinux 8 and #RedHat Enterprise Linux 8 👍 https://t.co/wGhCpYJYYQ #DNS #DNSmanagement #software #OS @4psa https://t.co/pLGvEFFNgn

  • Mashup Score: 4
    Wolters Kluwer Health - 2 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Results show that median overall survival #OS, 1-year survival rate and progression-free survival #PFS were longer in patients with advanced pancreatic cancer, KRAS wild-type disease when treated with nimotuzumab and gemcitabine @njuniversity #pancsm: https://t.co/HI3C62QKhD https://t.co/yuvzHcPgl2

  • Mashup Score: 7

    About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2022 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.

    Tweet Tweets with this article
    • Our #metaanalysis and network on pretreated #mesothelioma: 1. active Tx benefits either #PFS and #OS; 2. youngers (<65-70yr) benefit the most in OS; 3. any superior Tx, i.e. #Immunotherapy or #chemotherapy + #antiangiogenic @OncoViews @OncoAlert https://t.co/HJrs6nprfn https://t.co/PfOXyA5rUz